[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364043-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364043-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mortality-risk-in-patients-with-urological-malignancies-and-human-immunodeficiency-virus-hiv-coinfection-a-systematic-review-and-meta-analysis-of-cohort-studies","Mortality risk in patients with urological malignancies and human immunodeficiency virus (HIV) coinfection - A systematic review and meta-analysis of cohort studies","","Background: The extended survival of people living with human immunodeficiency virus (PLWH) has shifted cancer burdens toward urological malignancies. PLWH show distinctive clinical patterns, including younger diagnosis for renal cell carcinoma and more advanced prostate and bladder cancer stages, driven by healthcare access inequities and HIV-related mechanisms such as chronic immunosuppression. Methods: A systematic search across five databases up to 1 July 2025 pooled hazard ratios using random-effects models, with publication bias testing and sensitivity analyses. Results: Nine studies (6,615,444 participants) showed higher mortality risk in PLWH for kidney, prostate, and bladder cancers. Conclusion: HIV infection is significantly associated with increased mortality in prostate cancer; evidence is limited for kidney cancer and preliminary for bladder cancer, emphasizing need for integrated screening and tailored long-term HIV care.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mortality-risk-in-patients-with-urological-malignancies-and-human-immunodeficiency-virus-hiv-coinfection-a-systematic-review-and-meta-analysis-of-cohort-studies/364043/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mortality-risk-in-patients-with-urological-malignancies-and-human-immunodeficiency-virus-hiv-coinfection-a-systematic-review-and-meta-analysis-of-cohort-studies/364043.png","ImageObject",300,407,{"name":42,"@type":43},"mieayamfan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main finding on mortality risk for prostate cancer patients with HIV?","Question",{"text":63,"@type":64},"Prostate cancer patients infected with HIV had a significantly increased mortality risk, with an adjusted hazard ratio (aHR) of 2.27.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did HIV affect mortality risk in kidney cancer and bladder cancer patients?",{"text":68,"@type":64},"Compared with HIV-negative counterparts, HIV-positive kidney cancer patients had a 74% higher mortality risk (aHR = 1.74). For bladder cancer, data were limited but showed more than fourfold increased mortality risk (aHR = 4.29).",{"name":70,"@type":61,"acceptedAnswer":71},"What data sources and methods were used to estimate pooled mortality risk?",{"text":72,"@type":64},"The study searched five databases (Web of Science, PubMed, Cochrane Library, Embase, and Scopus) up to 1 July 2025. Random-effects models pooled hazard ratios and adjusted hazard ratios, publication bias was assessed using Egger’s test, and sensitivity analyses were performed.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364043,1790298263,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Cancer Pathogenesis and Therapy 4 (2026) 393–401  \nContents lists available at ScienceDirect  \nCancer Pathogenesis and Therapy  \njournal [homepage:](homepage: www.journals.elsevier.com/cancer-pathogenesis-and-therapy)[ www.journals.elsevier.com/cancer-pathogenesis-and-therapy](homepage: www.journals.elsevier.com/cancer-pathogenesis-and-therapy)  \nMeta-analysis  \nMortality risk in patients with urological malignancies and human immunodeficiency virus (HIV) coinfection: A systematic review and meta-analysis of cohort studies☆  \nYihang Zhang a, b, 1, Fei Zhao a, b, 1, Defu Yuan c, 1, Yueyu Huangd, Taiyi Jiang a, b, Tong Zhang a, b, Hao Wu a, b, Yu Zhang e, An Zhao d, Zhiqiang Zhu e, **, Bin Sua, b, f, g, *  \na Beijing Key Laboratory for HIV/AIDS Research, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China  \nb Sino-French Joint Laboratory for HIV/AIDS Research, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China  \nc Department of Epidemiology and Health Statistics, Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing, Jiangsu 210009, China  \nd Zhejiang Cancer Institute, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang 310000, China e Department of Urology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China  \nf Central Laboratory, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China  \ng The Scientific and Technological Achievement Transformation Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China  \nH I G H L I G H T S G R A P H I C A L A B S T R A C T  \n• Prostate cancer patients infected with human immunodeficiency virus (HIV) have a significantly increased risk of mortality, with an adjusted hazard ratio (aHR) of 2.27.  \n• Compared with their HIV-negative counterparts, HIV-positive kidney cancer patients have a 74% higher risk of mortality (aHR = 1.74).  \n• Although the data are limited, bladder cancer patients with HIV exhibited amore than fourfold increased risk of mortality (aHR = 4.29).  \n☆ Given his role as Youth Editorial board member, Prof. Bin Su had no involvement in the peer-review of this article and has no access to information regarding its peer-review. Full responsibility for the editorial process for this article was delegated to Managing Editor, Peng Lyu.  \n* Corresponding author.  \n** Corresponding author.  \nE-mail addresses: [zhuzhiqiang1001@mail.ccmu.edu.cn](zhuzhiqiang1001@mail.ccmu.edu.cn) (Z. Zhu), [binsu@ccmu.edu.cn](binsu@ccmu.edu.cn) (B. Su).  \n1 Yihang Zhang, Fei Zhao, and Defu Yuan contributed equally to this work.  \n[https://doi.org/10.1016/j.cpt.2026.02.003](https://doi.org/10.1016/j.cpt.2026.02.003)  \nReceived 19 September 2025; Received in revised form 6 February 2026; Accepted 25 February 2026  \n2949-7132/© 2026 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA). This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \nY. Zhang et al. Cancer Pathogenesis and Therapy 4 (2026) 393–401  \nA R T I C L E I N F O  \nManaging Editor: Peng Lyu  \nKeywords:  \nHuman immunodeficiency virus PLWH  \nUrological malignancies Mortality  \nA B S T R A C T  \nBackground: The extended survival of people living with human immunodeficiency virus (HIV) (PLWH) has shifted cancer burdens toward urological malignancies. PLWH exhibit unique clinical patterns, including a younger age at diagnosis for renal cell carcinoma and more advanced stage at presentation of prostate and bladder cancers, which are compounded by inequities in health care access and HIV-specific mechanisms such as chronic immunosuppression.  \nMethods: A systematic search was conducted across five databases (W","cbCairUhqDiA6uTD","https://ap.wps.com/l/cbCairUhqDiA6uTD","pdf",3060330,"English","# Meta-analysis\n## Highlights\n## Abstract\n## Introduction","[{\"question\":\"What was the main finding on mortality risk for prostate cancer patients with HIV?\",\"answer\":\"Prostate cancer patients infected with HIV had a significantly increased mortality risk, with an adjusted hazard ratio (aHR) of 2.27.\"},{\"question\":\"How did HIV affect mortality risk in kidney cancer and bladder cancer patients?\",\"answer\":\"Compared with HIV-negative counterparts, HIV-positive kidney cancer patients had a 74% higher mortality risk (aHR = 1.74). For bladder cancer, data were limited but showed more than fourfold increased mortality risk (aHR = 4.29).\"},{\"question\":\"What data sources and methods were used to estimate pooled mortality risk?\",\"answer\":\"The study searched five databases (Web of Science, PubMed, Cochrane Library, Embase, and Scopus) up to 1 July 2025. Random-effects models pooled hazard ratios and adjusted hazard ratios, publication bias was assessed using Egger’s test, and sensitivity analyses were performed.\"}]","Mortality risk in patients with urological malignancies and human immunodeficiency virus (HIV) coinfection - A systematic review and meta-analysis of cohort studies | PDF",1790155274,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6c7a058551a7e52669e0d59e0e18146.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8711389484ab79fb1701a38bb84d846f.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f91fe7dab3f7498256ddf29c15d9e4e.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd199afd2efe3e55d3d7fad2b9c642df.webp",980,1306]